Contact Us

Boston Scientific NexStent
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date the device was implanted:

Is the device still implanted?

What medical condition prompted the use of the device?

Please describe any problems or injuries caused by the product:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Boston Scientific NexStent

Boston Scientific NexStent Side Effects Lawsuits | Side Effects: Blood Vessel Damage, Stroke, Emergency Surgery |  Device Malfunctions, Faulty Monorail System, Defective Stent

Boston Scientific NexStent Side Effects May Result In Stroke Lawsuits

Boston Scientific NexStent | Lawsuits, Lawyers | Side Effects: Blood Vessel Damage, Stroke, Emergency Surgery | Device Malfunctions, Faulty Components, Defective Stent

The lawyers and attorneys at our firm are offering free case evaluations to individuals injured by Boston Scientific NexStent products. Boston Scientific recalled its NexStent carotid artery products in June 2008 because the defective devices could lead to blood vessel damage, stroke or emergency surgery. If you or someone you know were injured by Boston Scientific's NexStent Monorail, NexStent Carotid Stent or Monorail Delivery System, we urge you to contact one of our NexStent injury lawyers as soon as possible to protect your rights.

Boston Scientific first made its customers aware of the NexStent products recall in June 2008. This was done via a letter sent to customers on June 6, 2008. However, the recall was not made public until August 2008. For that reason, many victims of NexStent injuries might not even realize that the device was to blame. Our NexStent injury lawyers are committed to making sure that Boston Scientific treats victims of this defective device fairly.

Boston Scientific NexStent Recall

NexStent was approved by the Food & Drug Administration (FDA) in October 2006 to help keep the neck's carotid arteries propped open after they have been cleared of fatty blockages. The stent uses one of two delivery systems called the Monorail and Over the Wire, according to the FDA. The recall applies to the Monorail system as well as the stent itself.

The NexStent recall was initiated because the tip of the device used to implant the stent can break off and may damage the blood vessel wall or lead to stroke. If the device malfunctions, emergency surgery could be required to remove the tip. Such devastating injuries can take a horrible toll on victims and their families. Our NexStent injury lawyers will work hard to make sure those suffering because of this defective device receive the compensation they deserve.

The recall, which includes NexStent products made from June 2007 to May 2008, did not affect stents that have already been implanted, the FDA said. However, the NexStent injury lawyers know that these defective devices have been implanted in hundreds of people. Because most adverse events are never reported to the FDA, there is no way to know how many patients might have been injured by NexStent products.

FDA Deemed the NexStent recall a Class I Recall

Class I Recalls are for dangerous or defective products that predictably could cause serious health problems or death.

The FDA said that healthcare professionals and consumers may report any problems with the NexStent system to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by FAX. Patients with questions about recalled NexStent products should contact their doctors.

NexStent Products

The NexStent Carotid Stent is a laser-cut, nitinol stent with a rolled sheet design that enables one stent size to adapt to multiple diameters in tapered or non-tapered vessel configurations. Its self-sizing feature is designed to provide adaptability when treating lesions in the carotid arteries, and its closed-cell configuration is designed to increase lesion coverage and provide a smooth inner lumen to help facilitate delivery and retrieval of ancillary devices.

NexStent products are used in patients to treat a blockage (stenosis) in the carotid artery, known as carotid artery disease. The two carotid arteries (located on either side of the neck) supply blood to the brain. The device is used in a procedure called carotid artery stenting (CAS), in which the physician places the self-expanding stent in the carotid artery to keep the artery open and to help prevent future narrowing of the artery.

Legal Help for Victims of NexStent Injuries

If your or a loved one suffered a stroke, damage to blood vessel walls, or had to undergo emergency surgery because of a defective NexStent product, you have valuable legal rights. Please fill out our online form or call 1-800 YOURLAWYER (1-800-968-7529) to discuss your case with an experienced NexStent injury lawyer.


Boston Scientific NexStentRSS Feed

Recall for Boston Scientific Implantable Defibrillators

Mar 16, 2010 | Parker Waichman LLP
A massive recall is being issued for seven brands of Boston Scientific implantable heart defibrillators.  The recall is being issued because Boston Scientific has determined that it did not get approval from federal regulators for changes to its manufacturing processes. According to a Boston Scientific press release, the company is halting sales and retrieving field inventory of all its implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators...

Lawsuits Allege Medtronic, Other Firms Illegally Marketed Surgical Ablation Products

Jul 16, 2009 | Parker Waichman LLP
Medtronic Inc., St. Jude Medical Inc., AtriCure Inc. and Boston Scientific Corp. all allegedly paid kickbacks to doctors in order to convince them to use their surgical ablation products to treat the heart-rhythm defect called atrial fibrillation, according to lawsuits recently unsealed in Texas.   According to The Wall Street Journal, the lawsuits were filed by former employees of the companies.Allegations of kickbacks by medical device makers are nothing new.  For example, in...

NexStent Carotid Artery Stents Recalled by Boston Scientific

Aug 15, 2008 | Parker Waichman LLP
Boston Scientific said yesterday that it has recalled its NexStent products because of a defective stent delivery system.  The Food & Drug Administration (FDA) has deemed the NexStent recall a Class I recall.  Such recalls are for dangerous or defective products that predictably could cause serious health problems or death.NexStent products are used in patients to treat a blockage (stenosis) in the carotid artery, known as carotid artery disease. The two carotid arteries (located...

More Boston Scientific NexStent News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo